[Federal Register Volume 61, Number 62 (Friday, March 29, 1996)]
[Notices]
[Page 14104]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-7725]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


National Cancer Institute; Notice of Meeting

    Notice is hereby given of the meeting of the National Cancer 
Institute Board of Scientific Advisors Prevention Program Working 
Group, April 17, 1996 at The Bethesda Ramada, 8400 Wisconsin Avenue, 
Bethesda, Maryland.
    This meeting will be open to the public on April 17, from 8 a.m. to 
3:30 p.m. for overview and discussion of the Institute's Prevention 
Program.
    The meeting will be closed to the public on April 17, from 3:45 
p.m. to adjournment for discussion of confidential issues relating to 
the review, discussion and evaluation of individual programs and 
projects conducted by the Clinical Trials Extramural Program. These 
discussions will reveal confidential trade secrets or commercial 
property such as patentable material, and personal information 
including consideration of personnel qualifications and performance, 
the competence of individual investigators and similar matters, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Information pertaining to the meeting may be obtained from Dr. Jack 
Gruber, Executive Secretary, National Cancer Institute Prevention 
Program Working Group, National Cancer Institute, 6130 Executive Blvd., 
EPN, Rm. 540, Bethesda, MD 20892, (301-496-9740). Individuals who plan 
to attend and need special assistance such as sign language 
interpretation or other reasonable accommodations should contact Dr. 
Jack Gruber in advance of the meeting.

    Dated: March 25, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-7725 Filed 3-28-96; 8:45 am]
BILLING CODE 4140-01-M